2024 (11) TMI 936
X X X X Extracts X X X X
X X X X Extracts X X X X
....- COMPETITION COMMISSION OF INDIA (LB) - TMI<br>COMPETITION COMMISSION OF INDIA (LB) - CCI<br>Dated:- 25-4-2024<br>Case No. 01 of 2024 - -<br>Law of Competition<br>In Re: Dev Marketing Agency, Burnet Pharmaceuticals (S.S. Twari)/IDMA, North City Hospital, R.G. Hospitals, Medica Super Speciality Hospital, Food Safety & Standards Authority, Eastern Regional Office, Mr. Tapan Kanti Rudra (IAS, West B....
X X X X Extracts X X X X
X X X X Extracts X X X X
....ation Powder Composition Comprising Papain' is stated to be a dietary supplement/ modified ORS, which improves digestion, reduces pain and inflammation etc. The said product, marketed under the brand name 'Protestin', is sold in sachets by Reserca Health Care Pvt. Ltd. 3. The Informant has alleged that 'Protestin' is not being marketed and promoted because of non-cooperation by private hospitals,....
X X X X Extracts X X X X
X X X X Extracts X X X X
....40 units in March, 6,320 units in April, 11,920 units in May and 7,200 units in June of 2023. 5. Based on the above, the Informant has alleged contravention of Section 3(4) read with Section 3(1) of the Act and prayed for the following reliefs: i. Allowing free and fair marketing from all premises including specified areas (MNCs, private hospitals, West Bengal Fair Price Shop etc.) and others (....
X X X X Extracts X X X X
X X X X Extracts X X X X
....The Informant has stated that the alleged conduct of Opposite Parties is in contravention of Section 3(4) read with Section 3(1) of the Act. 8. The Commission observes that Section 3(4) of the Act requires existence of an agreement between vertically related players and that the said agreement has caused or is likely to cause appreciable adverse effect on competition in markets in India. 9. The ....